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PalatogenesisThe BMP signaling plays a pivotal role in the development of craniofacial organs, including the tooth and
palate. BmprIa and BmprIb encode two type I BMP receptors that are primarily responsible for BMP signaling
transduction. We investigated mesenchymal tissue-speciﬁc requirement of BmprIa and its functional
redundancy with BmprIb during the development of mouse tooth and palate. BmprIa and BmprIb exhibit
partially overlapping and distinct expression patterns in the developing tooth and palatal shelf. Neural crest-
speciﬁc inactivation of BmprIa leads to formation of an unusual type of anterior clefting of the secondary
palate, an arrest of tooth development at the bud/early cap stages, and severe hypoplasia of the mandible.
Defective tooth and palate development is accompanied by the down-regulation of BMP-responsive genes
and reduced cell proliferation levels in the palatal and dental mesenchyme. To determine if BmprIb could
substitute for BmprIa during tooth and palate development, we expressed a constitutively active form of
BmprIb (caBmprIb) in the neural crest cells in which BmprIa was simultaneously inactivated. We found that
substitution of BmprIa by caBmprIb in neural rest cells rescues the development of molars and maxillary
incisor, but the rescued teeth exhibit a delayed odontoblast and ameloblast differentiation. In contrast,
caBmprIb fails to rescue the palatal and mandibular defects including the lack of lower incisors. Our results
demonstrate an essential role for BmprIa in themesenchymal component and a limited functional redundancy
between BmprIa and BmprIb in a tissue-speciﬁc manner during tooth and palate development.l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The family of bone morphogenetic proteins (BMPs) comprises over
20 multi-functional cytokines that belong to the TFG-β superfamily.
BMPs play many important roles in embryonic development, postnatal
growth, and regeneration. BMP signaling is transduced into cell via
heteromeric receptor complexes of type I and type II transmembrane
serine–threonine kinase receptors. Binding of BMP ligands to a
heteromeric receptor complex induces phosphorylation of the type I
receptor in the GS domain by the type II receptor. The activated type I
receptor further phosphorylates in the cytoplasm the receptor-
regulated Smads, primarily Smad-1, -5, and -8, which bind to common
Smad (Smad4) andenter thenucleuswhere theSmad complex interacts
with other transcription factors to regulate gene expression (Sieber
et al., 2009). Besides this canonical BMP signaling pathway, BMPs can
also activate Smad-independent mitogen-activated protein kinase
(MAPK) signaling pathways. In addition to the two originally identiﬁed
type I BMP receptors (BMPR-IA and BMPR-IB), Activin receptor type IA(ActRIa or Alk2) also binds toBMP ligands and transduces BMP signaling
(Kawabata et al., 1998; Nohe et al., 2004). While mice deﬁcient for
BmprIb are viable with appendicular skeleton defects (Baur et al., 2000;
Yi et al., 2000), mutations in either BmprIa or Alk2 lead to embryonic
lethality during early gestation stage (Mishina et al., 1995, 1999; Gu
et al., 1999), suggesting distinct and potentially redundant roles
between these receptors during embryonic development.
The development of mammalian tooth and palate is governed by
interactions between pharyngeal ectoderm and cranial neural crest-
derived mesenchyme. Among many regulators, BMP signaling plays a
pivotal role in mediating the epithelial–mesenchymal interaction
during the development of these craniofacial organs (Nie et al., 2006).
During palatogenesis, several Bmp genes, including Bmp2, Bmp3,
Bmp4, Bmp5, and Bmp7, exhibit dynamic and differential expression
patterns along the anterior–posterior (A–P) axis of the developing
palatal shelves (Lu et al., 2000; Zhang et al., 2002; Hilliard et al., 2005;
Nie et al., 2006; Levi et al., 2006). In the anterior portion of developing
palatal shelves, Bmp4,Msx1, Shh, and Bmp2 form a genetic hierarchy to
regulate cell proliferation (Zhang et al., 2002); and BMP signaling is
also required for the expression of Shox2 whose inactivation causes
formation of a rare type of anterior clefting of the secondary palate in
mice (Yu et al., 2005; Gu et al., 2008). In the posterior palate, a
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epithelial integrity (Xiong et al., 2009; He et al., 2010). Numerous
studies have implicated BMP signaling in many aspects of tooth
development, from determination of tooth-forming sites and tooth
types (Neubüser et al., 1997; Tucker et al., 1998), progression from the
bud stage to the cap stage and formation of the enamel knot (Chen
et al., 1996; Jernvall et al., 1998; Zhang et al., 2000; Zhao et al., 2000),
to tooth root formation and tooth eruption (Yamashiro et al., 2003;
Hosoya et al., 2008, Huang et al., 2010, Yao et al., 2010). Among those
Bmp genes that are expressed in developing tooth, Bmp4 was
suggested to play a central role as a morphogen during early tooth
morphogenesis (Vainio et al., 1993; Thesleff and Mikkola, 2002).
The crucial role of BMP signaling in tooth andpalate developmentwas
further revealed by studies that used mice carrying conditionally
inactivated type I BMP receptors. In contrast to the lack of any visible
craniofacial defect in BmprIb null mice (Baur et al., 2000; Yi et al., 2000),
tissue-speciﬁc inactivation of BmprIa in the palatal and dental epithelium
results in a cleft palate formation and an arrest of molar development at
the bud/cap stages and causes various incisor phenotypes depending on
different Cre transgenicmouse lines that were used (Andl et al., 2004; Liu
et al., 2005). Furthermore, tissue-speciﬁc deletion of Alk2 in the neural
crest lineage leads to multiple craniofacial defects including cleft palate
and hypoplastic mandible; however, a tooth phenotypewas not reported
in this study (Dudas et al., 2004). Despite that these receptors are highly
homologous and can activate both Smad and Smad-independent path-
ways, and that they may function redundantly to certain extent, each of
themmediates speciﬁc and non-redundant signaling during embryogen-
esis (Sieber et al., 2009).
Despite the essential role for BmprIa in the epithelial component
for tooth and palate development, the requirement of BmprIa in the
mesenchymal component remains unknown. This is likely due to the
unavailability of a dental and palatal mesenchyme-speciﬁc Cre deletor
mouse line and the fact that mice bearing deletion of BmprIa in the
neural crest cell byWnt1-Cre die around E12.5 when tooth and palate
development just starts (Stottmann et al., 2004). It was recently
demonstrated that embryonic lethality in mice lacking BmprIa in the
neural crest lineage is due to norepinephrine depletion instead of
cardiac defects (Morikawa et al., 2009). Administration of the
β-adrenergic receptor agonist isoproterenol prevents embryonic
lethality, and Wnt1Cre;BmprIaF/− embryos survive to term, making
it possible to examine the role of BmprIa throughout development of
neural crest-derived tissues. Taking this advantage, we investigated
the role of BmprIa in the mesenchymal tissue and further tested if
BMPR-IB-mediated signaling is able to substitute for the loss of BmprIa
in tooth and palate development.
Materials and methods
Animals and embryo collection
The generation and genotyping of transgenic and gene-targeted
animals, includingWnt1-Cre,BmprIa+/−, BmprIaF/F, have beendescribed
previously (Mishina et al., 1995; Danielian et al., 1998). The pMes-
caBmprIb conditional transgenic line contains a constitutively active
form (with Gln203 to Asp change) of BMPR-IB (named caBmprIb),
which is linked to the 5′ end of the IRES-Egfp sequence and to the 3′ end
of the LoxP ﬂanked STOP cassette, under the control of the chick β-actin
promoter, as described previously (He et al., 2010). Embryos containing
inactivated BmprIa in their neural crest cells (Wnt1Cre;BmprIaF/−) were
obtained by crossing Wnt1Cre;BmprIa+/− mice with BmprIaF/F line. To
obtain embryos carrying Wnt1Cre;BmprIaF/− alleles and a pMes-
caBmprIb transgenic allele, Wnt1Cre;BmprIa+/− mice were crossed
with BmprIaF/+;pMes-caBmprIb mice. Mice containing such com-
pounded alleles are referred asWnt1Cre;BmprIaF/−;caIb.
Embryoswith BmprIa deﬁciency in their neural crest cells (Wnt1Cre;
BmprIaF/−) die at E12.5 (Stottmann et al., 2004), due to norepinephrinedepletion (Morikawa et al., 2009). Administration of the β-adrenergic
receptor agonist isoproterenol prevents embryonic lethality, allowing
Wnt1Cre;BmprIaF/− embryos to survive to term (Morikawa et al., 2009).
This was done by supplementing the drinking water of dams with
200 μg/ml isoproterenol and 2.5 mg/ml ascorbic acid from 7.5 post-
coitum(dpc), as describedpreviously (Morikawa andCserjesi, 2008). To
be consistent, all embryos used throughout this study, including the
wild-type controls, Wnt1Cre;BmprIaF/−, and Wnt1Cre;BmprIaF/−;caIb,
were obtained from dams fed with isoproterenol and ascorbic acid.
Embryos were collected from timed-mate pregnant females in ice-
coldPBS. Embryonic head samplesweredissected andﬁxed individually
in 4% paraformaldehyde (PFA) overnight at 4 °C, and processed for
parafﬁn section for histological and in situ hybridization analyses or for
frozen section for immunostaining. A tail sample form each embryowas
used for PCR-based genotyping (primers information available upon
request).
Mouse kidney capsule grafting
For subrenal culture in mice, E13.5 embryos were harvested from
mating of Wnt1Cre;BmprIa+/− mice with BmprIaF/+;pMes-caBmprIb
mice, and placed in PBS on ice. Embryos carrying Wnt1Cre;BmprIaF/−
orWnt1Cre;BmprIaF/−;caIb compounded alleles exhibited craniofacial
abnormalities and could be easily distinguished from embryos with
other genotypes. Wnt1Cre;BmprIaF/−;caIb embryo could be further
distinguished fromWnt1Cre;BmprIaF/−mice by the expression of Egfp
in craniofacial region. Tail samples from targeted embryos were
subjected to genotyping. E13.5 embryos collected from crosses of
wild-type mice were used as positive control. Mandibular molar
germs were isolated fromWnt1Cre;BmprIaF/−;caIb embryos and wild-
type controls and were subjected to subrenal culture. Adult CD-1male
mice were used as hosts for subrenal culture. Mice were anesthetized
by intraperitoneal injection of Newbutal sodium solution at a dose of
0.01 mg/g of body weight. Kidney capsule grafting was performed
following the procedure described in details previously (Zhang et al.,
2003). Samples were harvested 2 weeks after subrenal culture.
Histology, in situ hybridization, and immunostaining
For histological and in situ hybridization analyses, parafﬁn sections
were made at 10 μm and subjected for standard hematoxylin/eosin
staining and non-radioactive in situ hybridization, as described
previously (St. Amand et al., 2000). Frozen sections, made at 10 μm,
were applied for immunohistochemical staining, as described previ-
ously (Xiong et al., 2009). Polyclonal antibodies against p-Smad1/5/
8 were purchased from Cell Signaling (cat. #: 9511) and used at the
concentration of 1:200. Green ﬂuorescent-conjugated secondary
antibodies were obtained from Invitrogen.
Cell proliferation and TUNEL assays
BrdU labeling was performed to determine cell proliferation rate,
and TUNEL assay was applied to detect apoptotic cells, as described
previously (Zhang et al., 2002; Alappat et al., 2005). These were done
by using BrdU Labeling and Detection Kit and In Situ Cell Death
Detection Kit, both from Roche Diagnostics Corporation. Cell prolif-
eration rates were measured by counting BrdU-positive cells and total
cells in deﬁned arbitrary areas in the palatal and dental mesenchyme,
respectively. The outcome was presented as percentage of labeled
cells among total cells in the deﬁned arbitrary areas. Three continuous
sections from each of three individual samples of wild type and
mutants were counted, respectively. The sums from both genotypes
were subjected to Student's t-test to determine the signiﬁcance of
difference. Three independent BrdU labeling experiment with 6
samples of each genotype and four independent TUNEL assay with 4
samples of each genotype were performed.
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Expression of BmprIa and BmprIb in the developing tooth and palate
Numerous previous studies have implicated BMP signaling in tooth
and palate development. However, detailed expression patterns of
BmprIa and BmprIb during tooth and palate development have not beenFig. 1. Expression of BmprIa and BmprIb in developing tooth and palate. (A, E) At E13.5, Bmpr
restricted in the epithelium in lower incisor (E). (B, D) BmprIb is expressed in the epithelium o
at E13.5, BmprIa (E) and BmprIb (F) are expressed in the epithelium and mesenchyme. Not
compared to its expression in the lower molar (F). (G–J) At E14.5, BmprIa is continuously ex
(H) molars, but BmprIb expression is restricted to molar epithelium, particularly in the inner
palatal shelf. In the anterior palate, both BmprIa (K) and BmprIb (L) are expressed in the palat
the epithelium and mesenchyme at relatively lower levels (M); however, no BmprIb expre
epithelium; dm, dental mesenchyme; PS, palatal shelf.documented. We therefore began with examination of BmprIa expres-
sion in the developing tooth at several critical developmental stages,
including the bud, the cap, and the bell stages, and in the developing
secondary palatal shelves. BmprIb expression was also examined in
parallel. In the developing tooth at the E13.5 bud stage, both BmprIa and
BmprIb exhibit overlapped but distinct expression patterns (Fig. 1A–F).
In the upper (maxillary) incisors, BmprIa is expressed in both dentalIa expression is detected in the epithelium and mesenchyme of upper incisor (A) but is
f both upper (B) and lower (D) incisor at the same stage. (E, F) In the developing molars
e that BmprIb exhibits a higher level of expression in the upper molar mesenchyme as
pressed in both the epithelial and mesenchymal compartments of upper (G) and lower
enamel epithelium (I, J). (K–N) Expression of BmprIa (K, M) and BmprIb (L, N) in E13.5
al epithelium andmesenchyme. In the posterior palate, BmprIa expression is observed in
ssion is detected (N). Dashed lines demarcate dental epithelium. T, tongue; de, dental
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incisors, BmprIa expression is restricted in the dental epithelium
(Fig. 1C). BmprIb is only expressed in the dental epithelium of both
upper and lower incisor germs at this stage (Fig. 1B, D). In themolars, a
relatively lower level of BmprIa expression was observed in the dental
epithelium and mesenchyme, with a scattered pattern in the mesen-
chyme (Fig. 1E). BmprIb is also expressed in the epithelium and
mesenchyme, with a much stronger level in the upper molar
mesenchyme as compared to its expression in the lower molar
(Fig. 1F). At the E14.5 cap stage, BmprIa remains its expression in both
epithelial and mesenchymal compartments of upper incisors and
molars, and in the epithelium of lower incisor (Fig. 1G, H, and
Supplemental Fig. 1). In contrast, BmprIb is restrictedly expressed in
the dental epithelium of all types of tooth germ, with a high level in the
future inner enamel organ of molars (Fig. 1I, J, and Supplemental Fig. 1).
At the E16.5 bell stage, BmprIa expression is mainly restricted in the
epithelial component of upper and lower incisors, but an above
background expression was also observed in the dental papilla of
upper incisors.We also detected BmprIa expression in the inner enamel
epithelium as well as odontoblasts in molars (Supplemental Fig. 1). At
this stage, BmprIb expression becomes weaker and is completely
restricted in thedental epitheliumof incisors andmolars (Supplemental
Fig. 1).
In the developing palatal shelves at E12.5 and E13.5, BmprIa is
expressed in the epithelium and mesenchyme of the anterior palate,
while in the posterior palate, BmprIa expression is mainly restricted in
the palatal epithelium, with an above background level in the
mesenchyme (Fig. 1K, M, and Supplemental Fig. 1). At the same
stages, BmprIb is only expressed in the anterior portion of the palatal
shelf in both the epithelium and mesenchyme, but its expression is
completely absent in the posterior palatal mesenchyme (Fig. 1L, N,
and Supplemental Fig. 1).
Neural crest inactivation of BmprIa causes formation of an unusual type
of cleft palate
To generate embryos that were deﬁcient for BmprIa in the neural
crest cells, we crossed Wnt1Cre;BmprIa+/− mice to BmprIaF/F mice. In
order to obtain Wnt1Cre;BmprIaF/− embryos at term, dams were fed
with isoproterenol and ascorbic acid in drinking water to prevent
embryonic lethality at mid-gestation stage (Morikawa and Cserjesi,
2008; Morikawa et al., 2009). Wild-type mice or mice with other
genotypes exceptWnt1Cre;BmprIaF/−micewere indistinguishable with
mice from dams fed with normal drinking water. Gross examination of
Wnt1Cre;BmprIaF/− mice identiﬁed dramatic craniofacial defects,
including an extremely shortened mandible, hypoplastic maxillary
prominence, and an unusual type of anterior clefting of the secondary
palate (Fig. 2A–D). The shortened mandible with hypoplastic distal
region exposed the tongue to external view (Fig. 2B). Histological
analysis of E13.5 mutant embryo revealed shortened but horizontally
positioned palatal shelves in the anterior region (Fig. 1F). However, the
posteriorpalatal shelves in themutant assumedavertical position as the
wild-type control and appeared similar to the control in size and shape
(Fig. 2G, H). At E14.5when the palatal shelves inwild-type control have
elevated to the position above the tongue and met at the midline, the
palatal shelves in the mutant were also positioned above the tongue
(Fig. 2I–L). While the posterior palatal shelves inmutants made contact
at the midline, the anterior palatal shelves appeared too short to makeFig. 2. Wnt1Cre;BmprIaF/− mice exhibit a unique anterior clefting of the secondary palate
postnatal day 0 (P0) reveals craniofacial defects, including extremely shortened mandible
clefting of the secondary palate (arrow) (D). (E–H) coronal sections of E13.5 wild-type co
positioned palatal shelves in the anterior region of mutant (F). The posterior palatal shelve
E14.5 when the palatal shelves meet and fuse at the midline at the anterior (I) and posterior
the anterior region (J) but do meet and fuse in the posterior region (L). M, Meckel's cartilag
maxillary prominence. Asterisk in panel (J) marks palate clefting. Arrow in panel (B) point
palate. Scale bars represent 100 μm.contact. This unique type of cleft palate defect was also observed in
Shox2 mutant mice (Yu et al., 2005; Gu et al., 2008). In addition, a
deformed tongue was also seen in mutants. Thus deletion of BmprIa in
the neural crest-derived palatalmesenchyme causes a defective growth
in the anterior palatal shelves and ultimately leads to the formation of
anterior cleft of the secondary palate, consistent with a restricted
expression of BmprIa in the anterior palatal mesenchyme. BmprIa is
required not only in the epithelium (Andl et al., 2004; Liu et al., 2005)
but also in the mesenchyme for normal palate development.
Deletion of BmprIa in neural crest-derived mesenchyme arrests tooth
development
Histological examination failed to identify any deﬁnite tooth
structure inWnt1Cre;BmprIa newborn mice (data not shown), suggest-
ing a defective tooth development at early phase. Analysis of mutant
embryos at E13.5 revealed formation ofmolars at the bud stage (Fig. 3F),
However, as compared to the wild-type controls (Fig. 3E), the molar
buds in the mutant appeared a little bit delay in development with less
condensed dental mesenchymal cells surrounding the epithelial bud.
The incisor phenotype inmutants appearedmuch dramatic (Fig. 3A–D).
The upper incisors formed a single, medially located tooth bud that was
arrested at the early bud stage (Fig. 3B), while the lower incisor buds
never formed (Fig. 3D), likely due to a substantially shortenedmandible
(Fig. 2B). At the E16.5 bell stage, in mutants, we could not ﬁnd any
residual structure of upper incisors (Fig. 3H), but observe residualmolar
germs (Fig. 3L). Among 8 samples examined, all the lower molars were
arrested at the bud stage, but 6 residual upper molars appeared to be
arrested at the early cap stage (Fig. 3L). Taking together, these
observations indicate an absolute requirement of BmprIa in the
mesenchyme for tooth development beyond the bud stage or the
early cap stage.
Reduced cell proliferation in the palatal and tooth mesenchyme of
Wnt1Cre;BmprIaF/− embryos
To ensure that deletion of BmprIa in the neural crest cells disrupts
BMP signaling in the palatal and dental mesenchyme, we examined
the expression of phosphorylated Smad1/5/8 (pSmad1/5/8) by
immunohistochemical staining. In wild-type controls at E13.5, we
detected abundant pSmad1/5/8-positive cells in the anterior palatal
mesenchyme primarily on the future nasal side, and in the condensed
dental mesenchyme as well as the dental epithelium (Fig. 4A, C). In
contrast, as we expected, the number of pSmad1/5/8-positive cells
was signiﬁcantly reduced in the palatal and dental mesenchyme of
Wnt1Cre;BmprIaF/− mutants, although the staining in the epithelial
compartment remained unchanged (Fig. 4B, D).
To investigate cellular defects that may contribute to a cleft palate
formation and to the arrest of tooth development inWnt1Cre;BmprIaF/−
mutants, we carried out BrdU labeling and TUNEL assays to examine cell
proliferation rate and apoptosis. In the developing palatal shelves of
mutants at E13.5, we found a signiﬁcantly reduced level of cell
proliferation in the mesenchyme of the anterior palate, as compared
to that in the controls (Fig. 4E, F, I). However, cell proliferation rates in
the palatal epithelium and the posterior palatal mesenchyme remained
unchanged (data not shown). Similarly, in the developing molar of
mutants at this stage, a dramatic reduction in cell proliferation rate was
also found in the dental mesenchyme, but not in the dental epithelium. (A–D) Gross examination of wild type (A, C) and Wnt1Cre;BmprIaF/− (B, D) mice at
and hypoplastic maxillary prominence (asterisks) (B), and an unusual type of anterior
ntrol (E, G) and Wnt1Cre;BmprIaF/− (F, H) embryos reveal shortened and horizontally
s appear morphologically comparable in wild-type control and mutant (G, H). (I–L) At
(K) domains in wild-type control, the mutant palatal shelves appear too short to meet in
e; T, tongue; PP, primary palate; PS, palatal shelf. Asterisks in panels (A) and (B) mark
s to exposed tongue, and in panel (D), points to the anterior clefting of the secondary
455L. Li et al. / Developmental Biology 349 (2011) 451–461(Fig. 4G, H, I; and data not shown). The reduction in cell proliferation
rate correlates with a reduced level of pSmad1/5/8 in mutants,
indicating a positive role for BMP/Smad signaling in the regulation ofcell proliferation. On the other hand, TUNEL assays did not reveal
enhanced/ectopic cell apoptosis in the tooth germs and palatal shelves
of mutants at this stage (data not shown). Thus, this reduced cell
Fig. 3.Wnt1Cre;BmprIaF/−mice show defective tooth development. (A, C) Coronal sections of an E13.5 wild-type embryo show upper incisors (A) and lower incisors (C) at the bud
stage. (B, D) Coronal sections of an E13.5Wnt1Cre;BmprIaF/− embryo show a fused upper incisor at the early bud stage (B) and lack of lower incisors (D). (E, F) Coronal sections of an
E13.5 wild-type embryo (E) and an E13.5 mutant show molar teeth at the bud stage. Note that the mutant molars appear slightly delay in development and have less condensed
dental mesenchyme (F). (G, I) Sections show upper incisors (G) and lower incisors (I) in an E16.5 wild-type embryo. (H, J) Sections from an E16.5 mutant embryo show complete
lack of upper incisor (H) and lower incisor (J). (K) Coronal section from an E16.5 wild-type embryo shows molar teeth at the bell stage. (L) Coronal section from an E16.5 mutant
shows residual molar tooth structure. Note that the upper molar is arrested at the early cap stage, while the lower molar is arrested at the bud stage. Dashed lines demarcate dental
epithelium. T, tongue; LI, lower incisor; LM, lower molar; NS, nasal septum; UI, upper incisor; UM, upper molar.
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defective cellular mechanism contributing to a cleft palate formation
and an arrest of tooth development inWnt1Cre;BmprIaF/−mutants.Altered gene expression in the developing palate and tooth of Wnt1Cre;
BmprIaF/− mice
Mutations in several genes that are expressed in the mesenchymal
compartment of developing tooth and palate, including Msx1 and
Pax9, cause cleft palate defect as well as arrested tooth development
at the bud stage (Satokata andMaas, 1994; Peters et al., 1998). Bmp4 is
expressed and forms a positive regulatory loop with Msx1 in the
anterior palatal mesenchyme and the dental mesenchyme (Chen
et al., 1996; Peters et al., 1998; Zhang et al., 2000; Zhang et al., 2002).
We therefore set to examine the expression of these genes in the
developing palate and tooth of Wnt1Cre;BmprIaF/− mice. Since Shox2
expression pattern overlaps with that of BmprIa in the anterior palatal
mesenchyme and inactivation of Shox2 leads to the formation of
anterior cleft of the secondary palate in mice (Yu et al., 2005; Gu et al.,
2008), we also examined Shox2 expression. Our results revealed a
signiﬁcant down-regulation of Bmp4,Msx1, and Pax9 expression in the
anterior palatal mesenchyme of E13.5 Wnt1Cre;BmprIaF/− mice
(Fig. 5). Shox2 expression was also reduced in mutants (Fig. 5).
Similarly, in the developing tooth germ of mutants, the expression of
Bmp4, Msx1, and Pax9 was signiﬁcantly down-regulated in the
mesenchyme at the bud stage (Fig. 6). However, residual expression
for all these genes was present in the mutant dental mesenchyme.
Interestingly, the upper molars in mutants appeared to retain a
relatively higher level of Msx1 expression in the mesenchyme as
compared to the lower molars (Fig. 6B). This observation correlates
with a stronger BmprIb expression in the upper molar mesenchyme
(Fig. 1F) and an arrest of upper molar development at a relatively
advanced stage (the early cap stage) in the majority of mutants,
suggesting a partially functional redundancy between BmprIa and
BmprIb. Nevertheless, our results indicate that BMPR-IA is a major
mediator of BMP signaling in the regulation of Msx1 and Pax9
expression, which in turn is required for Bmp4 expression in thepalatal and dental mesenchyme (Chen et al., 1996; Peters et al., 1998;
Zhang et al., 2000, 2002).
caBMPR-IB partially rescues tooth development but not cleft palate
defect in Wnt1Cre;BmprIaF/− mice
To determine if BMPR-IB-mediated BMP signaling can substitute
for BMPR-IA-mediated signaling in regulating tooth and palate
development, we created a conditional transgenic allele that
expresses a constitutively active form of BMP receptor-IB (caBmprIb)
upon crossing to a Cre mouse line. While activation of the caBmprIb
allele in the epidermis by a K14-Cre transgenic allele causes severe
ichthyosis skin disease (Yu et al., unpublished), expression of
caBmprIb in the neural crest cells activated by Wnt1-Cre does not
produce any visible phenotype (data not shown). Wnt1Cre;caBmprIb
mice survived normally and were indistinguishable from their wild-
type littermates. In situ hybridization assay conﬁrmed a wide spread
expression of BmprIb in the cranial neural crest-derived mesenchyme,
including the palate shelf and tooth germ at E13.5 (Supplemental
Fig. 2). We compounded the caBmprIb transgenic allele onto the
Wnt1Cre;BmprIaF/− background to generate mice lacking BmprIa but
expressing caBmprIb in the neural crest cells (Wnt1Cre;BmprIaF/−;
caIb). Grossly,Wnt1Cre;BmprIaF/−;caIbmice exhibited similar cranio-
facial abnormalities indistinguishable from Wnt1Cre;BmprIaF/− mice,
including hypoplastic mandible and anterior clefting of the secondary
palate (data not shown). MostWnt1Cre;BmprIaF/−;caIb embryos died
at mid-gestation if the drinking water of dams did not contain
isoproterenol and ascorbic acid, except one that was identiﬁed at the
birth (data not shown). These results indicate that caBmprIb fails to
substitute for the loss of BmprIa to regulate craniofacial and peripheral
nervous system development.
Histological analyses conﬁrmed the phenotype of anterior palate
clefting inWnt1Cre;BmprIaF/−;caIbmice (data not shown), consistent
with failed restoration of Bmp4, Msx1, Pax9, and Shox2 expression in
the anterior palatal mesenchyme (Fig. 5). In contrast, althoughwe still
could not ﬁnd any residual structure of lower incisors, we observed
tooth structures of upper incisors and both upper and lower molars in
Wnt1Cre;BmprIaF/−;caIb newborn mice (Fig. 7A–D). While slight
Fig. 4. Reduced levels of BMP/Smad signaling activity and cell proliferation in the
palatal mesenchyme and dental mesenchyme of Wnt1Cre;BmprIaF/− embryo. (A, C)
Immunostaining shows pSmad1/5/8 signals in the palatal shelf (A) and an upper molar
(C) of an E13.5 wild-type embryo. The white line in panel (A) bisects the palatal shelf
into nasal and oral halves. Note that pSmad1/5/8 signals are mainly detected in the
nasal half of the palatal shelf. (B, D) Immunostaining shows signiﬁcantly reduced
pSmad1/5/8 signals in the palatal mesenchyme (B) and dental mesenchyme (D) of an
E13.5 mutant. (E–H) BrdU labeling shows reduced cell proliferation rates in the palatal
mesenchyme (F) of anterior palate and molar mesenchyme (H) of E13.5 mutant
embryos as compared to their wild-type counterparts (E, G). Squares indicate the areas
where cells were counted. Dashed lines in panels (G, H) demarcate dental epithelium.
(I) Comparison of BrdU-labeled cells in designated areas of palate and molar in controls
and mutants. Standard deviation values were shown as error bars, and ** indicates
Pb0.001. N designates nasal side of the palatal shelf, and O designates oral side of the
palatal shelf. de, dental epithelium; dm, dental mesenchyme; MT, mutant; WT, wild
type.
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BmprIaF/−;caIb mice indeed formed and appeared comparable to the
wild-type controls in developmental stage and patterning (Fig. 7B).
The rescued tooth development is consistent with an almost
completely restored Msx1 expression and partially rescued Bmp4
and Pax9 expression in molar mesenchyme at the bud stage (Fig. 6).
However, while the upper incisors developed, they formed adjacently,
appeared much smaller in size, and did not extend to the lateral sides
of the nasal cavity (Fig. 7D). Closer examination of the upper incisors
also revealed a mis-patterned incisor structure. In normal developing
incisors, ameloblasts form only in the future labial side (Fig. 7C).
However, in the upper incisors of Wnt1Cre;BmprIaF/−;caIb mice,
ameloblasts were found around the dental pulp (Fig. 7D′).
Wild-type molars at birth (P0) have formed differentiated
ameloblasts and odontoblasts, as evidenced by their polarized
(elongated) cell structure, expression of Amelogenin and Dspp, and
formation of dentin (Fig. 7E, G, I). However, while elongated
ameloblasts were observed in the molars of Wnt1Cre;BmprIaF/−;caIb
mice at the same age, neither elongated odontoblasts nor dentin were
found (Fig. 7F). This was also true for the upper incisors in Wnt1Cre;
BmprIaF/−;caIb mice (Fig. 7C, D). The lack of odontoblast differenti-
ation was consistent with the absent expression of the odontoblast
differentiation marker Dspp (Fig. 7J). Interestingly, despite their
elongated morphology, ameloblasts in the rescued molars and upper
incisors of Wnt1Cre;BmprIaF/−;caIb mice expressed an extremely low
level, if there is any, of the ameloblast differentiation marker
Amelogenin (Fig. 7H, and data not shown).
To determine if the absent Dspp and Amelogenin expression in the
rescued teeth of Wnt1Cre;BmprIaF/−;caIb mice at birth represents a
delay in tooth development and differentiation, we grafted mandib-
ular molars from E13.5 Wnt1Cre;BmprIaF/−;caIb embryos and wild-
type controls underneath mouse kidney capsule. After 2 weeks in
subrenal culture, the wild-type grafts produced well-organized
enamel and dentin (Fig. 7K). In Wnt1Cre;BmprIaF/−;caIb grafts, we
observed elongated odontoblasts and ameloblasts, and dentin deposit
(Fig. 7L). In situ hybridization analyses showed Amelogenin expression
in the ameloblasts (Fig. 7L′), and Dspp expression in the odontoblasts
(Fig. 7L″). These results conﬁrm a delayed differentiation of
odontoblasts and ameloblasts in Wnt1Cre;BmprIaF/−;caIb mice. Thus
caBmprIb can substitute for the loss of BmprIa in the cranial neural
crest cells to regulate tooth development, but it is unable to fully
replace BmprIa function as evidenced by delayed odontoblast and
ameloblast differentiation.
Discussion
In this study, we show detailed expression patterns of BmprIa and
BmprIb in the developing tooth and secondary palate. While previous
studies have uncovered a crucial role for BmprIa in the epithelial
component in tooth and secondary palate development (Andl et al.,
2004; Liu et al., 2005), our results demonstrate an absolute requirement
of BmprIa in the mesenchymal compartment for the development of
tooth and secondary palate as well. Cre-mediated loss of mesenchymal
BmprIa leads to an anterior clefting of the secondary palate and an arrest
of tooth development at the bud/early cap stage, which is accompanied
by reduced expression of BMP signaling downstream genes and
defective cell proliferation. Our rescue studies further show a limited
functional redundancy between BmprIa and BmprIb in a tissue-speciﬁc
manner in the development of craniofacial organs.
Mesenchymal BmprIa is required for anterior palate development
Increasing evidence has demonstrated heterogeneity, at both the
cellular and molecular levels, in the developing secondary palatal
shelf along the A–P axis (reviewed in Hilliard et al., 2005; Okano et al.,
2006; Gritli-Linde, 2007). At the molecular level, a number of genes
Fig. 5. Gene expression in the developing palatal shelves. (A, D, G, J) In situ hybridization shows expression of Bmp4 (A),Msx1 (D), Pax9 (G), and Shox2 (J) in the anterior palatal shelf
of E13.5 wild-type embryo. (B, E, H, K) Expression of Bmp4 (B), Msx1 (E), Pax9 (H), and Shox2 (K) is signiﬁcantly reduced in the anterior palatal shelf of E13.5 Wnt1Cre;BmprIaF/−
embryo. (C, F, I, L) Expression of Bmp4 (C),Msx1 (F), Pax9 (I), and Shox2 (L) remains down-regulated in the anterior palatal shelf of E13.5Wnt1Cre;BmprIaF/−;caIb embryo. T, tongue;
PS, palatal shelf.
458 L. Li et al. / Developmental Biology 349 (2011) 451–461exhibit differential expression in the developing palatal shelf along
the A–P axis (Zhang et al., 2002; Alappat et al., 2005; Yu et al., 2005;
He et al., 2008; Liu et al., 2008; Xiong et al., 2009). At the cellular level,
cells from the anterior palate and posterior palate respond differen-
tially to the induction of growth factors in terms of cell proliferation
and gene expression (Hilliard et al., 2005). For example, exogenously
applied BMP proteins induce cell proliferation andMsx1 expression in
the anterior palatal mesenchyme but not in the posterior palatal
mesenchyme (Zhang et al., 2002; Hilliard et al., 2005). This could be
explained by the restricted expression of both BmprIa and BmprIb in
the anterior palatal mesenchyme (Fig. 1). Consistently, tissue-speciﬁc
inactivation of BmprIa in the palatal mesenchyme results in defective
cell proliferation only in the anterior palatal mesenchyme and
consequently leads to an anterior clefting of the secondary palate.
These results indicate that BmprIa is a major player in mediating BMP
signaling in the regulation of cell proliferation in the palatal
mesenchyme. While BmprIb exhibits an expression pattern over-
lapping with BmprIa in the anterior palate, it apparently cannot
compensate for the loss of BmprIa. Therefore, BMPR-IA and BMPR-IBappear to mediate different downstream signaling pathways during
palatogenesis. In the anterior portion of palatal shelf, Msx1 and Bmp4
function in an autoregulatory loop to control a genetic cascade to
regulate cell proliferation (Zhang et al., 2002). In the absence of
BmprIa, expression of Msx1 and Bmp4, in addition to Pax9 which is a
key regulatory gene in palate development, is dramatically down-
regulated in the palatal mesenchyme. These results indicate an
essential role for BMPR-IA-mediated BMP4 signaling in the regulation
ofMsx1 and Pax9 expression. BMPR-IA is also required in the anterior
palatal mesenchyme for normal expression of Shox2 whose null
mutation leads to the formation of anterior cleft of the secondary
palate as well (Yu et al., 2005; Gu et al., 2008). This result is consistent
with our previous report that BMP signaling is required for Shox2
expression in the anterior palatal mesenchyme. However, based on
the facts that BMP signaling is not sufﬁcient for induction of Shox2
expression and a bioinformatic search fails to identify a potential
Smad binding site in the 10-kb upstream region of the mouse Shox2
gene (unpublished data), Shox2 is unlikely a direct target of BMP
signaling. Since loss of either Msx1 or Shox2 causes reduced cell
Fig. 6. Gene expression in developing molars. (A, D, G) In situ hybridization shows expression of Msx1 (A), Bmp4 (D), and Pax9 (G) in the molar mesenchyme of E13.5 wild-type
embryo. (B, E, H) In situ hybridization shows reduced expression ofMsx1 (B), Bmp4 (E), and Pax9 (H) in the molar mesenchyme of E13.5Wnt1Cre;BmprIaF/− embryo. (C, F, I) In situ
hybridization shows a wild-type level expression ofMsx1 (C) and a partially rescued Bmp4 (F) and Pax9 (I) expression in the molar mesenchyme of E13.5 Wnt1Cre;BmprIaF/−;caIb
embryo. Dashed lines demarcate dental epithelium. de, dental epithelium; dm, dental mesenchyme.
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Yu et al., 2005), the defective cell proliferation in the anterior palatal
mesenchyme of Wnt1Cre;BmprIa mice could be attributed to a
compounded effect of reduced expression of Msx1 and Shox2.
It was reported previously that deletion of BmprIa in the palatal
epithelium causes a complete clefting of the secondary palate (Andl
et al., 2004; Liu et al., 2005). In this study, inactivation of BmprIa in the
palatal mesenchyme also results in a cleft palate formation, indicating
the requirement of BMPR-IA-mediated signaling in both epithelium
and mesenchyme for normal palatogenesis. Anterior clefting of the
secondary palate is a rare type of cleft palate in humans and was
thought to be caused by a non-genetic mechanism known as post-
fusion rupture (Fara, 1971; Mitts et al., 1981; Schupbach, 1983).
Together with our previous report that Shox2-deﬁcient mice exhibit
anterior clefting of the secondary palate (Yu et al., 2005), our results
provide direct evidence for a genetic involvement in the formation of
such type of palate clefting.
Mesenchymal BmprIa is required for self-maintenance of Bmp4
expression in early tooth development
Previous studies have established a fundamental role for BMP
signaling in many steps of tooth development. Our studies further
reveal an essential role for BMPR-IA-mediated BMP signaling in the
dental mesenchyme during tooth development. Tissue-speciﬁc
deletion of BmprIa in the cranial neural crest derived dental
mesenchyme results in an arrest of molar development at the bud/
early cap stage, which is associated with signiﬁcant reduction in BMPactivity and defective cell proliferation. Mesenchymally expressed
BMP4 is required for progression of molar development from the bud
stage to the cap stage (Chen et al., 1996; Jernvall et al., 1998; Zhang
et al., 2000; Zhao et al., 2000). Msx1 and Pax9 act synergistically in
dental mesenchyme to regulate Bmp4 expression, which in turn
maintains Msx1 expression (Chen et al., 1996; Peters et al., 1998;
Ogawa et al., 2006; Nakatomi et al., 2010). Our gene expression
analyses show dramatically down-regulated expression of Bmp4,
Msx1, and Pax9 in Wnt1Cre;BmprIaF/- molar mesenchyme, indicating
that BMPR-IA also functions as a major player in the positive
regulatory loop involving Bmp4, Msx1, and Pax9. Given the fact that
BmprIb expression overlaps with that of BmprIa in molar germs before
the cap stage, the residual expression of Bmp4, Msx1, and Pax9 in the
Wnt1Cre;BmprIaF/− dental mesenchyme at the bud stage is likely
attributed to BmprIb expression. Obviously, the residual Bmp4
expression in the mutant dental mesenchyme is below the threshold
that is required for progression of molar development from the bud
stage to the cap stage. Interestingly, epithelial deletion of BmprIa also
causes an arrest of tooth development at the bud stage (Andl et al.,
2004; Liu et al., 2005), suggesting that BMPR-IA most likely also
mediates mesenchymally derived BMP4 signaling in the dental
epithelium for tooth progression to the cap stage.
Deletion of BmprIa in the mesenchymal compartment leads to
different defects in incisors. The mandibular incisor buds never
formed in Wnt1Cre;BmprIaF/− embryos. This phenotype is very likely
due to the formation of a hypoplastic mandible, which had severely
defective distal region (Fig. 2B). However, the maxillary incisor buds
fuse at the midline to form a single incisor bud, which is also arrested
Fig. 7. Rescue of tooth development in Wnt1Cre;BmprIaF/−;caIb mice. (A, C) Histological
sections show morphology of molars (A) and upper incisors (C) in postnatal day 0 (P0)
wild-typemice. (B) A histological section froma P0Wnt1Cre;BmprIaF/−;caIbmouse shows
molar structures that are comparable to wild-type control in developmental stage and
patterning. (D) A P0Wnt1Cre;BmprIaF/−;caIbmouse shows upper incisor teeth. These two
incisors formadjacently andunderneath thenasal septum. (D′) Highermagniﬁcation of an
upper incisor from panel (D) shows mis-patterned incisor structure, with ameloblasts
(arrowheads) forming all around the dental pulp. Black lines demarcate the ameloblast
layer. (E) A higher magniﬁcation image shows formation of elongated odontoblasts and
ameloblasts, and deposit of dentin in a molar of a P0 wild-type mouse. (F) A higher
magniﬁcation image shows formation of elongated ameloblasts, but lack of odontoblasts
and dentin deposit in a molar ofWnt1Cre;BmprIaF/−;caIbmouse at P0. (G, I) Expression of
Amelogenin in ameloblasts (G) and Dspp in odontoblasts (I) is detected in P0 wild-type
molars. (H, J) Molars from P0 Wnt1Cre;BmprIaF/−;caIb mouse fail to express Amelogenin
(H) andDspp (J). (K) Amolar germgraft from E13.5wild-type embryo shows formation of
enamel and dentin after 2-week in subrenal culture. (L) Amolar graft fromE13.5Wnt1Cre;
BmprIaF/−;caIb embryo shows differentiation of ameloblasts and odontoblasts and dentin
deposit. (L′) In situ hybridization shows Amelogenin expression in ameloblasts of molar
graft from Wnt1Cre;BmprIaF/−;caIb embryo. (L″) Dspp expression is detected in
odontoblasts of molar graft from Wnt1Cre;BmprIaF/−;caIb embryo. D, dentin; E, enamel;
Am, ameloblasts; LM, lowermolar; NS, nasal septum; Od, odontoblasts; Pd, pre-dentin; Sr,
stellate reticulum; UI, upper incisor; UM, upper molar.
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than that observed in molars in the mutants. This could be explained
by the complete lack of BmprIb expression in the upper incisor
mesenchyme at the bud stage (Fig. 1B) or could be attributed to
different requirement for levels of BMP signaling for development of
different types of tooth.
BmprIb has limited redundant function with BmprIa in the regulation of
craniofacial development
Bmp2 and Bmp4 are expressed in developing craniofacial organs
including palate and tooth and play important roles in the
development of these two organs (Nie et al., 2006). Both BMPR-IA
and BMPR-IB show high afﬁnity binding to BMP2 and BMP4 (Sieber
et al., 2009) and exhibit partially overlapping but distinct expression
patterns in the developing tooth and palatal shelf (this study). Despite
primary structural differences in their kinase domains, BMPR-IA and
BMPR-IB were shown previously to transduce similar intracellular
signals in cell cultures (Wozney et al., 1988; ten Dijke et al., 1994;
Hoodless et al., 1996; Kretzschmar et al., 1997). Several in vivo studies
using gain-of- or loss-of-function approaches seemed to be in favor of
a functional similarity between BMPR-IA and BMPR-IB in craniofacial
development. For examples, mice lacking BmprIb form normal
craniofacial structures, suggesting that BmprIamay take over BmprIb's
function during craniofacial development (Baur et al., 2000; Yi et al.,
2000). Expression of constitutively active forms of BMPR-IA or
BMPR-IB in chicken craniofacial region gave rise to similar pheno-
types, indicating that these two receptors may play similar role in
regulating bone and cartilage formation during craniofacial develop-
ment (Ashique et al., 2002). On the other hand, many lines of evidence
argue for distinct roles of these two BMP type I receptors in
embryogenesis. BmprIa-deﬁcient mice die prior to gastrulation,
revealing a fundamental role for BmprIa in early embryonic
development (Mishina et al., 1995). Expression of mutated forms of
BMPR-IA and BMPR-IB in the chicken limb buds produces distinct
phenotypes, suggesting that different BMP type I receptors are
dedicated to speciﬁc functions during organogenesis (Kawakami
et al., 1996; Yokouchi et al., 1996; Zou et al., 1997) In this study, we
show that, despite their overlapped expression patterns, BmprIb does
not share redundant function with BmprIa in the anterior palatal
mesenchyme to regulate palate development. BMPR-IA-mediated
signaling is irreplaceable for normal palatogenesis, as evidenced by
the rescue experiment in which caBmprIb fails to substitute for the
loss of BmprIa. In contrast, BmprIb appears to have limited functional
redundancy with BmprIa in dental mesenchyme for molar develop-
ment. This assumption is based on the facts: (1) BmprIb shows amuch
stronger expression level in the upper molar mesenchyme at the
E13.5 bud stage as compared to the lower molar (Fig. 1F); at the cap
stage, BmprIb expression is restricted to the dental epithelium of both
upper and lower molars (Fig. 1I, J); (2) inWnt1Cre;BmprIaF/−mice, all
lowermolars were arrested at the bud stage, but themajority of upper
molars developed to the early cap stage (Fig. 3L); (3) Msx1 retains a
relatively higher level of expression in the upper molar mesenchyme
as compared to its expression in the lower molar mesenchyme in
Wnt1Cre;BmprIaF/− embryo at the bud stage (Fig. 6B); (4) caBmprIb
was able to partially rescue tooth development (including molars and
upper incisor) in Wnt1Cre;BmprIaF/−;caIb mice (Fig. 7). The differen-
tial rescue of palate and tooth phenotypes inWnt1Cre;BmprIaF/−;caIb
mice suggests that these two type I receptors mediate different
signaling pathways in a tissue-speciﬁc manner. Taken together, our
results reveal an absolute requirement of BmprIa in the mesenchymal
component for normal palatogenesis and odontogenesis. BmprIb
shares limited redundant function with BmprIa in a tissue-speciﬁc
manner during craniofacial development.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2010.10.023.
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